Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz
Gewählte Publikation:
SHR Neuro Krebs Kardio Lipid Stoffw Microb
Chertow, GM; Raggi, P; Chasan-Taber, S; Bommer, J; Holzer, H; Burke, SK.
Determinants of progressive vascular calcification in haemodialysis patients.
Nephrol Dial Transplant. 2004; 19(6):1489-1496
Doi: 10.1093/ndt/gfh125
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
- Co-Autor*innen der Med Uni Graz
- Holzer Herwig
- Altmetrics:
- Dimensions Citations:
- Plum Analytics:
- Scite (citation analytics):
- Abstract:
- BACKGROUND: We determined recently that targeted treatment with calcium-based phosphate binders (calcium acetate and carbonate) led to progressive coronary artery and aortic calcification by electron beam tomography (EBT), while treatment with the non-calcium-containing phosphate binder, sevelamer, did not. Aside from the provision of calcium, we hypothesized that other factors might be related to the likelihood of progressive calcification in both or either treatment groups. METHODS: We explored potential determinants of progressive vascular calcification in 150 randomized study subjects who underwent EBT at baseline and at least once during follow-up (week 26 or 52). RESULTS: Among calcium-treated subjects, higher time-averaged concentrations of calcium, phosphorus and the calcium-phosphorus product were associated with more pronounced increases in EBT scores; no such associations were demonstrated in sevelamer-treated subjects. The relation between parathyroid hormone (PTH) and the progression of calcification was more complex. Lower PTH was associated with more extensive calcification in calcium-treated subjects, whereas higher PTH was associated with calcification in sevelamer-treated subjects. Serum albumin was inversely correlated with progression in aortic calcification. Sevelamer was associated with favourable effects on lipids, although the link between these effects and the observed attenuation in vascular calcification remains to be elucidated. CONCLUSION: Calcium-based phosphate binders are associated with progressive coronary artery and aortic calcification, especially when mineral metabolism is not well controlled. Calcium may directly or indirectly (via PTH) adversely influence the balance of skeletal and extraskeletal calcification in haemodialysis patients.
- Find related publications in this database (using NLM MeSH Indexing)
- Aged -
- Arteriosclerosis - epidemiology
- Blood Vessels - pathology
- Calcinosis - epidemiology
- Calcium - blood
- Comorbidity - blood
- Disease Progression - blood
- Epoxy Compounds - pharmacology
- Female - pharmacology
- Humans - pharmacology
- Kidney Failure, Chronic - epidemiology
- Male - epidemiology
- Parathyroid Hormone - epidemiology
- Phosphates - blood
- Polyamines - blood
- Polyethylenes - pharmacology
- Renal Dialysis - pharmacology
- Statistics, Nonparametric - pharmacology
- Tomography, X-Ray Computed - pharmacology
- Find related publications in this database (Keywords)
- calcium
- ESRD
- haemodialysis
- PTH
- sevelamer